Urolithiasis Clinical Trial
Official title:
Intravenous Paracetamol or Morphine for the Treatment of Acute Flank Pain : a Randomized, Double Blind, Controlled Clinical Trial
STUDY OBJECTIVE: This randomized, controlled trial evaluates the analgesic efficacy and
safety of intravenous single-dose paracetamol and morphine for the treatment of acute flank
pain.
METHODS: The investigators conducted a randomized, double-blind, controlled clinical trial
comparing single intravenous doses of paracetamol (1 g) and morphine (0.1 mg/kg) for
patients presenting to the emergency department (ED) with acute flank pain. Subjects with
inadequate pain relief at 30 minutes received rescue fentanyl (0.75 microg/kg).
Study Design and Setting:
This is a single-center, prospective, randomized, double-blind, clinical trial performed in
an ED of a tertiary care hospital with annual census of approximately 37.000 visits. The
local ethics committee approved the study.
Two treatment options, intravenous paracetamol and morphine, were compared for ceasing pain
in patients presented with renal colic.
Selection of Participants:
Patients, aged 18 to 55 years, with flank pain were accepted as eligible for the study.
Patients with clinical diagnosis of acute renal colic and declared to have moderate or
serious pain according to the 4-point verbal scale were included into the study.
Exclusion criteria were as follows: patients denied to give inform consent, use of any
analgesic within six hours of ED presentation, patients with fewer or hemodynamically
unstable, peritoneal irritation signs, cardiac failure, history of renal and hepatic
failure, prior known allergy to paracetamol or morphine, suspected or documented pregnancy
and patients with viewing problems. Patients suspected to have renal colic but ultimately to
have diagnosis such as renal abscess, renal infarction or renal venous thrombosis were also
excluded from the study.
Consecutive patients were enrolled into the study 24 hours a day and seven days a week by
the senior resident in the shift. The ultimate diagnosis of renal colic was performed by
displaying the stone either by ultrasonograph (USG) or computerized tomography (CT). USG was
the first choice for detecting the renal stone. CT was performed if a stone was not detected
by USG. After CT, patients who were not shown a urolithiasis or pathologies other than renal
colic were excluded from the study.
Interventions:
Study subjects were randomized in order to receive a single dose of either paracetamol
(Perfalgan, Bristol Myers Squibb, Itxassou, France), 1 gr in 100 ml normal saline, or
morphine (0.1 mg/kg in 100 ml normal saline) in a blinded fashion. The study drugs was
written in a paper which is folded four times and covered with sealed bands for allocation
concealment. The study nurse withdrew one of the drugs from a box. And they were prepared by
the study nurse and administered by the second nurse blinded to the study. Study drugs were
identical in color and appearance. Subjects with who needed rescue drug because of
inadequate pain relief were received fentanyl 1 μg/kg intravenously.
Methods of Measurements:
Subjects reported pain intensity on both a 100-mm visual analogue scale (limited by 'no
pain' and 'the worst pain') and a 4-point verbal rating scale (no pain, mild, moderate, or
severe pain) just before the drug administration, 15th minutes and 30th minutes after the
study drug administration. The demographic features of study patients and adverse effects,
nausea, vomiting, dizziness, vertigo, headache, hypotension, altered mental status, allergic
reaction, itching, urinary retention, thoracic rigidity, respiratory depression and dry
mouth, were recorded to the study form.
Outcome Measures The primary outcome measure was the pain reduction in VAS and VRS at 15th
and 30th minutes. Secondary outcome measures were the need for rescue drug and the presence
of any adverse event.
Primary Data Analysis:
The present study was planned as a superiority trial. When the 20 mm difference in VAS is
accepted as clinically significant and the standard deviation is accepted as 25 mm, 35
patients are needed with each group with 95% power. All the analysis were implemented
according to the intention to treat analysis. The precise of differences between time
intervals within groups and between groups and statistical significance were expressed by
95% confidence intervals (95% CI). All tests of significance were two sided.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |